Delaying radiation therapy for prostate cancer unlikely to affect survival during coronavirus disease 2019.
Published in Cancer
Published in Cancer
Published in Cancer
Breast cancer is one of the most common causes of cancer mortality for all women, including American Indian and Alaska Native (AI/AN) women. The use of the 21-gene recurrence score (RS) appears to be predictive of the benefit of chemotherapy for women with estrogen receptor (ER)-positive breast cancer. The objective of the current study was to comp...
Published in Cancer
This study was designed to test the hypothesis that the effectiveness of intensive treatment for locoregionally advanced head and neck cancer (LAHNC) depends on the proportion of patients' overall event risk attributable to cancer. This study analyzed 22,339 patients with LAHNC treated in 81 randomized trials testing altered fractionation (AFX; Met...
Published in Cancer
Supplemental breast cancer screening with breast magnetic resonance imaging (MRI) is recommended for women at high risk of breast cancer. To the authors' knowledge, recent national trends in breast MRI use are unknown. The authors used claims data from a large national insurer to calculate screening breast MRI rates from 2006 to 2016 in a US cohort...
Published in Cancer
State-specific breast density notification legislation requires that women undergoing mammography be informed about breast density, with variation among states. Because mammography facilities are among the main points of contact for women undergoing mammography, research is needed to understand how facilities communicate information on breast densi...
Published in Cancer
Published in Cancer
Published in Cancer
Published in Cancer
Published in Cancer
Prior literature has suggested synergy between immune checkpoint therapy (ICT) and radiotherapy (RT) for the treatment of brain metastases (BrM), but to the authors' knowledge the optimal timing of therapy to maximize this synergy is unclear. A total of 199 patients with melanoma and non-small cell lung cancer with BrM received ICT and RT between 2...